B of A Securities Reinstates Neutral on Cardlytics, Announces $11 Price Target
Portfolio Pulse from Benzinga Newsdesk
B of A Securities analyst Omar Dessouky has reinstated a Neutral rating on Cardlytics (NASDAQ:CDLX) and announced a price target of $11.
June 20, 2024 | 10:40 am
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
B of A Securities analyst Omar Dessouky has reinstated a Neutral rating on Cardlytics (NASDAQ:CDLX) and announced a price target of $11.
The Neutral rating suggests that the analyst does not expect significant short-term movement in the stock price. The $11 price target provides a benchmark for investors, but the neutral stance indicates a balanced view of potential risks and rewards.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100